Industry Focus

It’s big pharma week! First, we discuss Eli Lilly’s second quarter earnings and its decision to spin-off its animal health business. Then, we explain why GlaxoSmithKline became an investor in the DNA screening company, 23andMe.

Direct download: 20180725_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST